Keyphrases
Infertility
88%
Cisplatin
66%
Low-middle Income Countries
66%
Testicular Tissue
58%
Spermatogonial Stem Cell Line
50%
Antioxidant
50%
Cell number
50%
Fertility Restoration
50%
Sertoli Cells
50%
Platinum-based Chemotherapy
50%
Chemotherapy
50%
Cell Function
50%
Fertility Care
50%
Reproduction Method
50%
Fertility Clinics
50%
Assisted Reproductive Technology
50%
Low-resource Countries
50%
Political Community
26%
Human Fetus
22%
Reproductive Health
20%
Access to Treatment
20%
Anti-Mllerian Hormone
16%
Platinum-based
16%
Carboplatin
16%
Chemotherapy Drugs
16%
N-acetylcysteine
16%
SRY-box Transcription Factor 9 (SOX9)
16%
Doxorubicin
16%
Testicle
16%
Ovarian Stimulation Protocol
16%
Mild Ovarian Stimulation
16%
Private Settings
16%
Procreation
16%
Simplified IVF
16%
Effective Means
16%
Developed Countries
16%
Infertility Care
16%
Sociocultural Differences
16%
Clinical Community
16%
Responsible Stakeholder
16%
Developing Countries
16%
Low-resource Settings
16%
Reimbursement Mechanisms
16%
Affordable Cost
16%
Cancer Treatment
13%
Xenografting
11%
Sertoli Cell Function
11%
Inhibin B
11%
Prepubertal Testicular Tissue
11%
Chemotherapy Exposure
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Cisplatin
66%
Antioxidant
50%
Malignant Neoplasm
22%
Acetylcysteine
16%
Vincristine
16%
Carboplatin
16%
Doxorubicin
16%
Inhibin B
11%
Chemotherapy Agent
8%
Toxic Substance
8%
Melatonin
8%
Antiinfective Agent
5%
Childhood Cancer
5%
Retrospective Study
5%
